Greater Cannabis Company, Inc.

Trafalgar Asset Management, LLC, controlled by Porfirio Sanchez Talavera, acquired 100% of Greater Cannabis Company, Inc.'s Series A and Series B Preferred Stock on June 29, 2026. This transaction grants Trafalgar approximately 96.62% of the company's aggregate voting power, leading to a change in control. Concurrently, certain company indebtedness was compromised and cancelled. Following the change, Porfirio Sanchez Talavera was appointed Chief Executive Officer, Chairman of the Board, and a Director, while Aitan Zacharin resigned from all officer positions.

Greater Cannabis Company reported a net loss of $33,376 for the first quarter ended March 31, 2026, a reduction from the $103,511 loss in the prior year. The company continues to operate with no revenue, minimal cash of $1,439, and substantial current liabilities of $776,464, leading to a going concern warning. The company is focused on developing cannabinoid therapeutics, having concluded preclinical studies and received approval for a Phase II Clinical Trial, but is currently awaiting specialized API and additional funding to proceed.